Authors | Sattva S Neelapu, Caron A Jacobson, Olalekan O Oluwole, Javier Munoz, Abhinav Deol, David B Miklos, Nancy L Bartlett, Ira Braunschweig, Yizhou Jiang, Jenny J Kim, Lianqing Zheng, John M Rossi, Frederick L Locke |
Journal | Blood
(Blood)
Vol. 135
Issue 23
Pg. 2106-2109
(06 04 2020)
ISSN: 1528-0020 [Electronic] United States |
PMID | 32181801
(Publication Type: Clinical Trial, Phase I, Clinical Trial, Phase II, Letter, Multicenter Study, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antigens, CD19
- Biological Products
- axicabtagene ciloleucel
|
Topics |
- Adult
- Aged
- Antigens, CD19
(therapeutic use)
- Biological Products
- Female
- Follow-Up Studies
- Humans
- Immunotherapy, Adoptive
- Lymphoma, Large B-Cell, Diffuse
(immunology, pathology, therapy)
- Male
- Middle Aged
- Neoplasm Recurrence, Local
(immunology, pathology, therapy)
- Prognosis
- Survival Rate
- Young Adult
|